Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-049536)

Filing Details

Accession Number:: 0001209191-13-049536
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-10-28 17:22:49
Reporting Period:: 2013-10-25

Filing Date:: 2013-10-28
Accepted Time:: 2013-10-28 17:22:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
816284	Celgene Corp	CELG	Pharmaceutical Preparations (2834)	222711928

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1110753	Smith Carrie Cox	C/O Celgene Corporation 86 Morris Avenue Summit NJ 07901		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-10-25	18,750	$51.78	19,315	No	4	M	Direct
Common Stock	Disposition	2013-10-25	18,750	$157.67	565	No	4	S	Direct
Common Stock	Acquisiton	2013-10-25	6,150	$55.38	6,715	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2013-10-25	18,750	$0.00	18,750	$51.78
Common Stock	Stock Option (right to buy)	Disposition	2013-10-25	6,150	$0.00	6,150	$55.38

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,250		2019-12-16	No	4	M	Direct
0		2020-06-16	No	4	M	Direct

Footnotes

The option was fully exercisable.
The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as amended).